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Criteria for the processing of dengue samples at the  
CDC Dengue Branch, San Juan, Puerto Rico 
 
The CDC Dengue Branch provides dengue testing free of cost to submitting physicians, state and private 
laboratories. To adequately determine what laboratory tests are necessary, correctly provide a clinical 
diagnosis and to assure that test results are received by the requesting physician, the following 
information is essential: 
 Complete name, age and sex of the patient 
 Home address 
 Date of onset of symptoms  
 Date that sample was obtained 
 If the patient traveled prior to disease presentation, travel destination and dates need to be 
included. 
 Complete name and mailing address of the physician, laboratory, clinic or hospital that the 
result should be sent to. 
 
Samples without the above-mentioned information, written with illegible handwriting or with more 
than a month from date of sample collection to date of arrival at CDC, will not be tested. 
In circumstances of a dengue outbreak or cases of severe disease such as hemorrhagic manifestations, 
the CDC Dengue Branch will promptly analyze samples received with the minimum above-mentioned 
information.  If number of specimens exceeds laboratory capacity, testing may be prioritized in the 
following order: 
 cases in intensive care, 
 hospitalized cases (with thrombocytopenia, hemorrhage, shock or hemoconcentration 
 
 fatal cases ), 
 all other DF cases. 
 
 Case Notification and Shipment of Samples of Suspected Dengue Cases  
Dengue is an acute febrile illness. In addition to fever, headache, pain behind the eyes, body aches, rash, 
nausea and vomiting are common symptoms of dengue. Other variable symptoms can include 
hemorrhagic manifestations (such as a petechial rash) or hemoconcentration, shock or coma.  Serum 
samples from dengue suspected cases should be obtained as early as possible and submitted to State 
Health Department laboratories.  Samples obtained during the first 5 days of illness (acute samples) are 
likely to contain virus; whereas samples collected after 5 days of illness (convalescent samples) may 
contain antibodies against the virus. Samples can be submitted to the CDC Dengue Branch; following 
reporting to the State Laboratory.  
Instructions for obtaining and handling samples: 
1. Once there is a clinical diagnosis of suspected dengue, take a blood sample (see #3 to 5) and fill out 
the Dengue Case Investigation Form (see copy attached).  With this Form you comply with the legal 
reporting requirement.  These forms can be obtained from the CDC Dengue Branch website 
http://www.cdc.gov/dengue/resources/dengueCaseReports/DCIF_English.pdf or the Puerto Rico 
Department of Health website 
http://www.salud.gov.pr/Datos/VDengue/Documents/InformeInvestigacionCD.pdf.  Forms can also 
be photocopied without restriction. 
 
2. It is important to fill out the Dengue Case Investigation Form in a clear and complete manner.  The 
information received on each case (especially the date of onset of symptoms and date of sample 
collection) is crucial to determine the appropriate diagnostic test and interpret the laboratory 
results.  Furthermore, a complete address makes it possible to identify regions of transmission 
where control measures should be implemented. Samples without the above-mentioned 
information, or written in illegible handwriting or with more than a month from date of collection 
to date of arrival at CDC, will not be tested. 
 
3.   Serum samples are preferred for most dengue tests. The blood sample should be taken in a red-top  
or tiger-top tube. Citrate (collected in yellow top tubes) and heparin plasma (green top tubes) can 
be tested by RT-PCR. Violet-top (with EDTA) is not recommended for RT-PCR testing. Violet and or 
green-top tubes should not be used for serology testing (convalescent sample).  Please refer to 
collection devices manufacturer instructions for more details. After blood is allowed to clot, 
separate serum by centrifugation and keep serum refrigerated at 4 oC or frozen at -20 oC (preferred).  
4.  Specimen should be sent to the CDC-Dengue Branch (address mentioned on the Dengue Case 
Investigation Form). 
 For samples from the USA or abroad, we recommend to freeze the serum immediately after 
separated and to send on dry ice.  If dry ice is not available, we recommend that the serum is kept 
refrigerated and delivered to the CDC Dengue Branch in cold packs.  The case investigation forms 
and the acute serum sample should reach CDC Dengue Branch as soon as possible following 
collection; there is no need to wait until the convalescent sample is obtained.  Most dengue 
diagnostic tests practiced at the CDC-Dengue Branch have been validated in serum and plasma 
samples. Therefore, plasma separated in lavender (EDTA) or green (heparin) top tubes are 
acceptable for PCR testing only, not for serology testing. These samples should also be stored and 
sent to the CDC Dengue Branch in the conditions specified for sera.  
 
5. To diagnose dengue, the laboratory requires a serum sample obtained during the acute phase of the 
infection (DPO=0-5). If this sample is negative, then a second convalescent serum sample (that can 
be taken from day 6 after the onset of symptoms) is required to confirm the case.  Informing the 
patient about the importance of returning for a second sample, and providing an appointment for a 
specific day and hour, will increase the probability of obtaining the second sample.   
 
6. Acute-phase samples (taken on or before day 5 after onset of symptoms), will be tested by RT-PCR  
for virus detection and convalescent-phase samples (taken on or after day 6 after beginning of 
symptoms) will be tested for anti-dengue IgM antibodies by enzyme-linked immunosorbent assays 
(ELISA). Differential diagnosis for dengue and WN virus is available; but these tests need to be 
requested according to clinical presentation.   
                                 
 Type of 
sample 
Interval since 
the onset of symptoms 
Type of analysis 
“Acute” until day 5 RT-PCR 
“Convalescent” 6 or more days Serology 
 
Samples taken on days 4 and 5 of illness are of low yield for isolation as well as serology.   
WHENEVER THERE IS A HOSPITALIZED SEVERE CASE, PLEASE INDICATE on THE CASE INVESTIGATION 
FORM. 
 
7. Reports will be sent to the physician (if the return address has been indicated) with the results of 
positive or negative cases.  In cases with negative RT-PCR results, we will wait for a convalescent-
phase sample before reporting a result. If a convalescent sample is not obtained, the case will be 
considered indeterminate.  
 




Dengue Branch, CDC      
1324 Cañada St. 
Puerto Nuevo        Tel. (787) 706-2399 
San Juan, Puerto Rico  00920-3860    Fax (787) 706-2496  
 
Points of contact:   
Dr. Jorge Muñoz   ckq2@cdc.gov for molecular testing 
Dr. Elizabeth Hunsperger   enh4@cdc.gov for serology testing 
 CHECK LIST FOR OBTAINING AND SHIPPING DENGUE DIAGNOSTIC SAMPLES  
 
[  ] Sample 
 
Type of sample Interval since date  
of onset of symptoms 
Type of analysis 
Acute Up to 5 days RT-PCR 
Convalescent 6 or more days Serology 
 
 [  ] Form - "Dengue Case Investigation Form" 
Can be obtained from the CDC Dengue Branch in San Juan or Internet:  
http://www.cdc.gov/dengue/resources/dengueCaseReports/DCIF_English.pdf  Please indicate on 
the sheet if the case is hospitalized.  If it is a very severe case, indicate so on the "Comments" 
section. 
Only the samples received with the information requested below, and written in a legible 
manner, will be analyzed: 
 Complete name, age, and sex of patient 
 Home address 
 Date of onset of symptoms 
 Date sample was obtained 
 Complete name and mailing address of the physician, laboratory, clinic, or hospital  
 
[  ] Tube – Red, tiger-top or green top (not violet). 
[  ] Labeling - Tube and case form must agree (indicate the same name of the case). 
[  ] Volume  -  2 cc. (ml.) of centrifuged serum or plasma  
[  ] Storage  - On ice or in a refrigerator until it is delivered to the CDC Dengue Branch. 
[  ] Time of shipment - Not to exceed a month after taking the sample 
[  ] Way of shipment - Check with your local Department of Health.  
 
Reasons for REJECTING samples: 
 Samples without form, form without sample 
 Incomplete or illegible form – especially regarding date of onset of symptoms, date of 
sample collection 
 Hemolyzed or contaminated samples are not acceptable for serology testing 
 Samples received more than a month after onset of illness 
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